Switch theme
Sign up to access all valuation multiples
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
2001
9
LTM Revenue $0.2M
LTM EBITDA -$25.7M
$19.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Incannex has a last 12-month revenue of $0.2M and a last 12-month EBITDA of -$25.7M.
In the most recent fiscal year, Incannex achieved revenue of $12K and an EBITDA of -$18.5M.
Incannex expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Incannex valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | n/a | $12K | XXX | XXX | XXX |
| Gross Profit | -$4K | n/a | XXX | XXX | XXX |
| Gross Margin | -Infinity% | 0% | XXX | XXX | XXX |
| EBITDA | -$13.4M | -$18.5M | XXX | XXX | XXX |
| EBITDA Margin | -Infinity% | -154200% | XXX | XXX | XXX |
| Net Profit | -$10.3M | -$13.2M | XXX | XXX | XXX |
| Net Margin | -Infinity% | -110209% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Incannex's stock price is $1.
Incannex has current market cap of $17.9M, and EV of $19.9M.
See Incannex trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19.9M | $17.9M | XXX | XXX | XXX | XXX | $-1.46 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Incannex has market cap of $17.9M and EV of $19.9M.
Incannex's trades at 82.9x LTM EV/Revenue multiple, and -0.8x LTM EBITDA.
Analysts estimate Incannex's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Incannex and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $19.9M | XXX | XXX | XXX |
| EV/Revenue | 127.6x | XXX | XXX | XXX |
| EV/EBITDA | -0.9x | XXX | XXX | XXX |
| P/E | -0.8x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpIncannex's NTM/LTM revenue growth is 91%
Incannex's revenue per employee for the last fiscal year averaged $1K, while opex per employee averaged $2.1M for the same period.
Over next 12 months, Incannex's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Incannex's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Incannex and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | Infinity% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -14777% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 38% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -14686% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $1K | XXX | XXX | XXX | XXX |
| Opex per Employee | $2.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 8792% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 133467% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 107325% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 155158% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Incannex acquired XXX companies to date.
Last acquisition by Incannex was XXXXXXXX, XXXXX XXXXX XXXXXX . Incannex acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Incannex founded? | Incannex was founded in 2001. |
| Where is Incannex headquartered? | Incannex is headquartered in United States of America. |
| How many employees does Incannex have? | As of today, Incannex has 9 employees. |
| Who is the CEO of Incannex? | Incannex's CEO is Mr. Joel Latham. |
| Is Incannex publicy listed? | Yes, Incannex is a public company listed on NAS. |
| What is the stock symbol of Incannex? | Incannex trades under IXHL ticker. |
| When did Incannex go public? | Incannex went public in 2022. |
| Who are competitors of Incannex? | Similar companies to Incannex include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Incannex? | Incannex's current market cap is $17.9M |
| What is the current revenue of Incannex? | Incannex's last 12-month revenue is $0.2M. |
| What is the current EBITDA of Incannex? | Incannex's last 12-month EBITDA is -$25.7M. |
| What is the current EV/Revenue multiple of Incannex? | Current revenue multiple of Incannex is 82.9x. |
| What is the current EV/EBITDA multiple of Incannex? | Current EBITDA multiple of Incannex is -0.8x. |
| Is Incannex profitable? | Yes, Incannex is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
